{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T06:41:56Z","timestamp":1788244916002,"version":"build-2803163510"},"reference-count":89,"publisher":"Bentham Science Publishers Ltd.","issue":"3","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CTMC"],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:sec>\n<jats:title>:<\/jats:title>\n<jats:p>Medicinal plants have a long history of use as food and remedy in traditional and modern\nsocieties. They have been used as herbal drugs and sources of novel bioactive compounds.\nThey provide a wide array of chemical compounds, many of which can not be synthesized via current\nsynthesis methods. Natural products may provide aromatase inhibitory activity through various\npathways and may act clinically effective for treating pathologies associated with excessive aromatase\nsecretion, including breast, ovarian, and endometrial cancers, endometriosis, uterine fibroid,\nbenign prostatic hyperplasia (BPH), prostate cancer, infertility, and gynecomastia. Recent\nstudies have shown that natural products with aromatase inhibitory activity can also be good options\nagainst secondary recurrence of breast cancer by exhibiting chemopreventive effects. Therefore,\nscreening for new plant-based aromatase inhibitors may provide novel leads for drug discovery\nand development, particularly with increased clinical efficacy and decreased side effects.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1568026621666211129141631","type":"journal-article","created":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T04:35:55Z","timestamp":1638246955000},"page":"229-246","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The Role of Aromatase Enzyme in Hormone Related Diseases and Plant-\nBased Aromatase Inhibitors as Therapeutic Regimens"],"prefix":"10.2174","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8620-6402","authenticated-orcid":true,"given":"Kevser Taban","family":"Ak\u00e7a","sequence":"first","affiliation":[{"name":"Department of Pharmacognosy, Faculty of Pharmacy, Gazi University, 06330, Etiler, Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7082-8976","authenticated-orcid":true,"given":"Murside Ay\u015fe","family":"Demirel","sequence":"additional","affiliation":[{"name":"Department of\nBasic Pharmaceutical Sciences, Laboratory Animals Breeding and Experimental Research Center, Gazi University,\nFaculty of Pharmacy, 06330, Etiler, Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4201-1325","authenticated-orcid":true,"given":"Ipek","family":"S\u00fcntar","sequence":"additional","affiliation":[{"name":"Department of Pharmacognosy, Faculty of Pharmacy, Gazi University, 06330, Etiler, Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1055\/s-0029-1216276","volume":"27","author":"Herson P.S.","year":"2009","unstructured":"Herson P.S.; Koerner I.P.; Hurn P.D.; Sex, sex steroids, and brain injury. Semin Reprod Med 2009,27(3),229-239","journal-title":"Semin Reprod Med"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jsbmb.2017.01.009","volume":"168","author":"Patel S.","year":"2017","unstructured":"Patel S.; Disruption of aromatase homeostasis as the cause of a multiplicity of ailments: A comprehensive review. J Steroid Biochem Mol Biol 2017,168,19-25","journal-title":"J Steroid Biochem Mol Biol"},{"key":"ref=3","doi-asserted-by":"crossref","first-page":"646","DOI":"10.2174\/187152008785133092","volume":"8","author":"Balunas M.J.","year":"2008","unstructured":"Balunas M.J.; Su B.; Brueggemeier R.W.; Kinghorn A.D.; Natural products as aromatase inhibitors. Anticancer Agents Med Chem 2008,8(6),646-682","journal-title":"Anticancer Agents Med Chem"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1055\/s-2006-958033","volume":"61","author":"Gansser D.","year":"1995","unstructured":"Gansser D.; Spiteller G.; Aromatase inhibitors from Urtica dioica roots. Planta Med 1995,61(2),138-140","journal-title":"Planta Med"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1055\/s-2006-957624","volume":"63","author":"Ducrey B.","year":"1997","unstructured":"Ducrey B.; Marston A.; G\u00f6hring S.; Hartmann R.W.; Hostettmann K.; Inhibition of 5 alpha-reductase and aromatase by the ellagitannins oenothein A and oenothein B from Epilobium species. Planta Med 1997,63(2),111-114","journal-title":"Planta Med"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"3288","DOI":"10.1093\/jn\/131.12.3288","volume":"131","author":"Grube B.J.","year":"2001","unstructured":"Grube B.J.; Eng E.T.; Kao Y.C.; Kwon A.; Chen S.; White button mushroom phytochemicals inhibit aromatase activity and breast cancer cell proliferation. J Nutr 2001,131(12),3288-3293","journal-title":"J Nutr"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1021\/np010288l","volume":"64","author":"Lee D.","year":"2001","unstructured":"Lee D.; Bhat K.P.; Fong H.H.; Farnsworth N.R.; Pezzuto J.M.; Kinghorn A.D.; Aromatase inhibitors from Broussonetia papyrifera. J Nat Prod 2001,64(10),1286-1293","journal-title":"J Nat Prod"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1081\/IPH-200026840","volume":"26","author":"Lee T.K.","year":"2004","unstructured":"Lee T.K.; Kim D.I.; Han J.Y.; Kim C.H.; Inhibitory effects of Scutellaria barbata D. Don. and Euonymus alatus Sieb. on aromatase activity of human leiomyomal cells. Immunopharmacol Immunotoxicol 2004,26(3),315-327","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.phytol.2008.10.009","volume":"2","author":"Balunas M.J.","year":"2009","unstructured":"Balunas M.J.; Su B.; Riswan S.; Fong H.H.S.; Brueggemeier R.W.; Pezzuto J.M.; Kinghorn A.D.; Isolation and characterization of aromatase inhibitors from Brassaiopsis glomerulata (Araliaceae). Phytochem Lett 2009,2(1),29-33","journal-title":"Phytochem Lett"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1177\/1933719111398500","volume":"18","author":"Chen Y.","year":"2011","unstructured":"Chen Y.; Chen C.; Shi S.; Han J.; Wang J.; Hu J.; Liu Y.; Cai Z.; Yu C.; Endometriotic implants regress in rat models treated with puerarin by decreasing estradiol level. Reprod Sci 2011,18(9),886-891","journal-title":"Reprod Sci"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.biochi.2014.06.002","volume":"105","author":"Kim J.","year":"2014","unstructured":"Kim J.; Jayaprakasha G.K.; Patil B.S.; Obacunone exhibits anti-proliferative and anti-aromatase activity in\u00a0vitro by inhibiting the p38 MAPK signaling pathway in MCF-7 human breast adenocarcinoma cells. Biochimie 2014,105,36-44","journal-title":"Biochimie"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1002\/asia.201403253","volume":"10","author":"Pailee P.","year":"2015","unstructured":"Pailee P.; Prachyawarakorn V.; Ruchirawat S.; Mahidol C.; Bioactive cardinane sesquiterpenes from the stems of Alangium salviifolium. Chem Asian J 2015,10(4),910-914","journal-title":"Chem Asian J"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.jep.2018.06.009","volume":"224","author":"Dawood H.M.","year":"2018","unstructured":"Dawood H.M.; Ibrahim R.S.; Shawky E.; Hammoda H.M.; Metwally A.M.; Integrated in silico-in vitro strategy for screening of some traditional Egyptian plants for human aromatase inhibitors. J Ethnopharmacol 2018,224,359-372","journal-title":"J Ethnopharmacol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"114637","DOI":"10.1016\/j.taap.2019.114637","volume":"381","author":"Miao L.","year":"2019","unstructured":"Miao L.; Jiao C.; Shao R.; Qi Y.; Fan G.; Li X.; Wang Y.; Zhu Y.; Zhang J.; Gao X.; Bakuchiol suppresses oestrogen\/testosterone-induced Benign Prostatic Hyperplasia development through up-regulation of epithelial estrogen receptor \u03b2 and down-regulation of stromal aromatase. Toxicol Appl Pharmacol 2019,381,114637","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/cbdd.13635","volume":"95","author":"Ali A.","year":"2020","unstructured":"Ali A.; Jan N.U.; Ali S.; Ahmad B.; Ali A.; Samrana S.; Jahan A.; Ali H.; Khan I.A.; Rahim H.; Ali I.; Kifayatullah M.; Amin F.; Steroidal alkaloids efficient aromatase inhibitors with potential for the treatment of postmenopausal breast cancer. Chem Biol Drug Des 2020,95(2),233-239","journal-title":"Chem Biol Drug Des"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1093\/hmg\/ddm145","volume":"16","author":"Demura M.","year":"2007","unstructured":"Demura M.; Martin R.M.; Shozu M.; Sebastian S.; Takayama K.; Hsu W-T.; Schultz R.A.; Neely K.; Bryant M.; Mendonca B.B.; Hanaki K.; Kanzaki S.; Rhoads D.B.; Misra M.; Bulun S.E.; Regional rearrangements in chromosome 15q21 cause formation of cryptic promoters for the CYP19 (aromatase) gene. Hum Mol Genet 2007,16(21),2529-2541","journal-title":"Hum Mol Genet"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1210\/jcem.77.6.8117355","volume":"77","author":"Bulun S.E.","year":"1993","unstructured":"Bulun S.E.; Price T.M.; Aitken J.; Mahendroo M.S.; Simpson E.R.; A link between breast cancer and local estrogen biosynthesis suggested by quantification of breast adipose tissue aromatase cytochrome P450 transcripts using competitive polymerase chain reaction after reverse transcription. J Clin Endocrinol Metab 1993,77(6),1622-1628","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=18","first-page":"548","volume":"8","author":"Piriu G.","year":"2015","unstructured":"Piriu G.; Torac E.; Gaman L.E.; Iosif L.; Tivig I.C.; Delia C.; Gilca M.; Stoian I.; Atanasiu V.; Clozapine and risperidone influence on cortisol and estradiol levels in male patients with schizophrenia. J Med Life 2015,8(4),548-551","journal-title":"J Med Life"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1111\/jog.13743","volume":"44","author":"Mori T.","year":"2018","unstructured":"Mori T.; Ito F.; Koshiba A.; Kataoka H.; Tanaka Y.; Okimura H.; Khan K.N.; Kitawaki J.; Aromatase as a target for treating endometriosis. J Obstet Gynaecol Res 2018,44(9),1673-1681","journal-title":"J Obstet Gynaecol Res"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"2944","DOI":"10.1093\/humrep\/deq275","volume":"25","author":"Oktem O.","year":"2010","unstructured":"Oktem O.; Urman B.; Understanding follicle growth in vivo. Hum Reprod 2010,25(12),2944-2954","journal-title":"Hum Reprod"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/978-3-319-31973-5_7","volume":"58","author":"Rimon-Dahari N.","year":"2016","unstructured":"Rimon-Dahari N.; Yerushalmi-Heinemann L.; Alyagor L.; Dekel N.; Ovarian folliculogenesis. Results Probl Cell Differ 2016,58,167-190","journal-title":"Results Probl Cell Differ"},{"key":"ref=22","first-page":"pp. 377-398","author":"Monniaux D.","year":"2019","unstructured":"Monniaux D.; Cadoret V.; Cl\u00e9ment F.; Dalbies-Tran R.; Elis S.; Fabre S.; Maillard V.; Monget P.; Uzbekova S.; Folliculogenesis. In: Encyclopedia of Endocrine Diseases, 2 Ed.; Huhtaniemi, I.; Martini, L., Eds.; Academic Press: Oxford, 2019,pp. 377-398"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"818010","DOI":"10.1155\/2014\/818010","volume":"2014","author":"Gerv\u00e1sio C.G.","year":"2014","unstructured":"Gerv\u00e1sio C.G.; Bernuci M.P.; Silva-de-S\u00e1 M.F.; Rosa-E-Silva A.C.; The role of androgen hormones in early follicular development. ISRN Obstet Gynecol 2014,2014,818010","journal-title":"ISRN Obstet Gynecol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"pp. 72-79","DOI":"10.1016\/B978-0-12-801238-3.64628-7","author":"Hannon P.R.","year":"2018","unstructured":"Hannon P.R.; Curry T.E.; Folliculogenesis. In: Encyclopedia of Reproduction, 2 ed; Skinner, M.K., Ed.; Academic Press: Oxford, Encyclopedia of Reproduction 2018,pp. 72-79","journal-title":"Encyclopedia of Reproduction"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/S1472-6483(10)60009-0","volume":"18","author":"Altm\u00e4e S.","year":"2009","unstructured":"Altm\u00e4e S.; Haller K.; Peters M.; Saare M.; Hovatta O.; Stavreus-Evers A.; Velthut A.; Karro H.; Metspalu A.; Salumets A.; Aromatase gene (CYP19A1) variants, female infertility and ovarian stimulation outcome: a preliminary report. Reprod Biomed Online 2009,18(5),651-657","journal-title":"Reprod Biomed Online"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1196\/annals.1286.029","volume":"1007","author":"Carrer H.F.","year":"2003","unstructured":"Carrer H.F.; Cambiasso M.J.; Brito V.; Gorosito S.; Neurotrophic factors and estradiol interact to control axogenic growth in hypothalamic neurons. Ann N Y Acad Sci 2003,1007,306-316","journal-title":"Ann N Y Acad Sci"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.bone.2008.05.011","volume":"43","author":"Lanfranco F.","year":"2008","unstructured":"Lanfranco F.; Zirilli L.; Baldi M.; Pignatti E.; Corneli G.; Ghigo E.; Aimaretti G.; Carani C.; Rochira V.; A novel mutation in the human aromatase gene: insights on the relationship among serum estradiol, longitudinal growth and bone mineral density in an adult man under estrogen replacement treatment. Bone 2008,43(3),628-635","journal-title":"Bone"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"113737","DOI":"10.1016\/j.ejmech.2021.113737","volume":"224","author":"Giampietro L.","year":"2021","unstructured":"Giampietro L.; Gallorini M.; Gambacorta N.; Ammazzalorso A.; De Filippis B.; Della Valle A.; Fantacuzzi M.; Maccallini C.; Mollica A.; Cataldi A.; Nicolotti O.; Amoroso R.; Synthesis, structure-activity relationships and molecular docking studies of phenyldiazenyl sulfonamides as aromatase inhibitors. Eur J Med Chem 2021,224,113737","journal-title":"Eur J Med Chem"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1196\/annals.1386.022","volume":"1089","author":"Hong Y.","year":"2006","unstructured":"Hong Y.; Chen S.; Aromatase inhibitors: structural features and biochemical characterization. Ann N Y Acad Sci 2006,1089,237-251","journal-title":"Ann N Y Acad Sci"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"181","DOI":"10.2217\/WHE.11.5","volume":"7","author":"Pazaiti A.","year":"2011","unstructured":"Pazaiti A.; Fentiman I.S.; Basal phenotype breast cancer: implications for treatment and prognosis. Womens Health (Lond Engl) 2011,7(2),181-202","journal-title":"Womens Health (Lond Engl)"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/1477-7827-9-91","volume":"9","author":"Khan S.I.","year":"2011","unstructured":"Khan S.I.; Zhao J.; Khan I.A.; Walker L.A.; Dasmahapatra A.K.; Potential utility of natural products as regulators of breast cancer-associated aromatase promoters. Reprod Biol Endocrinol 2011,9,91-91","journal-title":"Reprod Biol Endocrinol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1186\/bcr2424","volume":"11 Suppl 3","author":"Darbre P.D.","year":"2009","unstructured":"Darbre P.D.; Underarm antiperspirants\/deodorants and breast cancer. Breast Cancer Res 2009,11 Suppl 3(Suppl 3),S5","journal-title":"Breast Cancer Res"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1200\/JOP.000082","volume":"6","author":"Burstein H.J.","year":"2010","unstructured":"Burstein H.J.; Griggs J.J.; Prestrud A.A.; Temin S.; American society of clinical oncology clinical practice guideline update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer. J Oncol Pract 2010,6(5),243-246","journal-title":"J Oncol Pract"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.maturitas.2013.11.009","volume":"77","author":"Schmid B.C.","year":"2014","unstructured":"Schmid B.C.; Oehler M.K.; New perspectives in ovarian cancer treatment. Maturitas 2014,77(2),128-136","journal-title":"Maturitas"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"5911","DOI":"10.1158\/1078-0432.CCR-12-1257","volume":"18","author":"Simpkins F.","year":"2012","unstructured":"Simpkins F.; Hevia-Paez P.; Sun J.; Ullmer W.; Gilbert C.A.; da Silva T.; Pedram A.; Levin E.R.; Reis I.M.; Rabinovich B.; Azzam D.; Xu X.X.; Ince T.A.; Yang J.Y.; Verhaak R.G.W.; Lu Y.; Mills G.B.; Slingerland J.M.; Src Inhibition with saracatinib reverses fulvestrant resistance in ER-positive ovarian cancer models in vitro and in vivo. Clin Cancer Res 2012,18(21),5911-5923","journal-title":"Clin Cancer Res"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1124\/pr.57.3.6","volume":"57","author":"Bulun S.E.","year":"2005","unstructured":"Bulun S.E.; Lin Z.; Imir G.; Amin S.; Demura M.; Yilmaz B.; Martin R.; Utsunomiya H.; Thung S.; Gurates B.; Tamura M.; Langoi D.; Deb S.; Regulation of aromatase expression in estrogen-responsive breast and uterine disease: from bench to treatment. Pharmacol Rev 2005,57(3),359-383","journal-title":"Pharmacol Rev"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1056\/NEJMcp1000274","volume":"362","author":"Giudice L.C.","year":"2010","unstructured":"Giudice L.C.; Clinical practice. Endometriosis. N Engl J Med 2010,362(25),2389-2398","journal-title":"N Engl J Med"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jsbmb.2018.04.004","volume":"181","author":"Takaoka O.","year":"2018","unstructured":"Takaoka O.; Mori T.; Ito F.; Okimura H.; Kataoka H.; Tanaka Y.; Koshiba A.; Kusuki I.; Shigehiro S.; Amami T.; Kitawaki J.; Daidzein-rich isoflavone aglycones inhibit cell growth and inflammation in endometriosis. J Steroid Biochem Mol Biol 2018,181,125-132","journal-title":"J Steroid Biochem Mol Biol"},{"key":"ref=39","first-page":"151","volume":"8","author":"Beavis A.L.","year":"2016","unstructured":"Beavis A.L.; Smith A.J.B.; Fader A.N.; Lifestyle changes and the risk of developing endometrial and ovarian cancers: opportunities for prevention and management. Int J Womens Health 2016,8,151-167","journal-title":"Int J Womens Health"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1093\/humupd\/dmi034","volume":"12","author":"Attar E.","year":"2006","unstructured":"Attar E.; Bulun S.E.; Aromatase and other steroidogenic genes in endometriosis: translational aspects. Hum Reprod Update 2006,12(1),49-56","journal-title":"Hum Reprod Update"},{"key":"ref=41","first-page":"415","volume":"11","author":"Zhang Y.","year":"2013","unstructured":"Zhang Y.; Cao H.; Yu Z.; Peng H-Y.; Zhang C-J.; Curcumin inhibits endometriosis endometrial cells by reducing estradiol production. Iran J Reprod Med 2013,11(5),415-422","journal-title":"Iran J Reprod Med"},{"key":"ref=42","first-page":"CD009505","author":"Song H.","year":"2013","unstructured":"Song H.; Lu D.; Navaratnam K.; Shi G.; Aromatase inhibitors for uterine fibroids. Cochrane Database Syst Rev 2013(10),CD009505","journal-title":"Cochrane Database Syst Rev"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1097\/01.AOG.0000136079.62513.39","volume":"104","author":"Wallach E.E.","year":"2004","unstructured":"Wallach E.E.; Vlahos N.F.; Uterine myomas: an overview of development, clinical features, and management. Obstet Gynecol 2004,104(2),393-406","journal-title":"Obstet Gynecol"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/S1472-6483(10)60246-5","volume":"17","author":"Gurates B.","year":"2008","unstructured":"Gurates B.; Parmaksiz C.; Kilic G.; Celik H.; Kumru S.; Simsek M.; Treatment of symptomatic uterine leiomyoma with letrozole. Reprod Biomed Online 2008,17(4),569-574","journal-title":"Reprod Biomed Online"},{"key":"ref=45","first-page":"53","volume":"13","author":"Shah C.","year":"2002","unstructured":"Shah C.; Nayak M.; Kulkarni K.; Use of PR2000, a Herbal Formulation in the Medical Management of Benign Prostatic Hyperplasia. 2002,13,53-66"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/S0014-827X(01)01067-9","volume":"56","author":"Vitalone A.","year":"2001","unstructured":"Vitalone A.; Bordi F.; Baldazzi C.; Mazzanti G.; Saso L.; Tita B.; Anti-proliferative effect on a prostatic epithelial cell line (PZ-HPV-7) by Epilobium angustifolium L. Farmaco 2001,56(5-7),483-489","journal-title":"Farmaco"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"207","DOI":"10.2174\/187152812800392715","volume":"11","author":"Azimi H.","year":"2012","unstructured":"Azimi H.; Khakshur A.A.; Aghdasi I.; Fallah-Tafti M.; Abdollahi M.; A review of animal and human studies for management of benign prostatic hyperplasia with natural products: perspective of new pharmacological agents. Inflamm Allergy Drug Targets 2012,11(3),207-221","journal-title":"Inflamm Allergy Drug Targets"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0303-7207(01)00433-6","volume":"178","author":"S\u00e9ralini G.","year":"2001","unstructured":"S\u00e9ralini G.; Moslemi S.; Aromatase inhibitors: past, present and future. Mol Cell Endocrinol 2001,178(1-2),117-131","journal-title":"Mol Cell Endocrinol"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/nrc2174","volume":"7","author":"Ellem S.J.","year":"2007","unstructured":"Ellem S.J.; Risbridger G.P.; Treating prostate cancer: a rationale for targeting local oestrogens. Nat Rev Cancer 2007,7(8),621-627","journal-title":"Nat Rev Cancer"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1093\/oxfordjournals.jncimonographs.a024244","author":"Bosland M.C.","year":"2000","unstructured":"Bosland M.C.; The role of steroid hormones in prostate carcinogenesis. J Natl Cancer Inst Monogr 2000(27),39-66","journal-title":"J Natl Cancer Inst Monogr"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1080\/14756366.2021.1937145","volume":"36","author":"Alhadrami H.A.","year":"2021","unstructured":"Alhadrami H.A.; Sayed A.M.; Melebari S.A.; Khogeer A.A.; Abdulaal W.H.; Al-Fageeh M.B.; Algahtani M.; Rateb M.E.; Targeting allosteric sites of human aromatase: a comprehensive in-silico and in-vitro workflow to find potential plant-based anti-breast cancer therapeutics. J Enzyme Inhib Med Chem 2021,36(1),1334-1345","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/0140-6736(92)90927-U","volume":"339","author":"Ross R.K.","year":"1992","unstructured":"Ross R.K.; Bernstein L.; Lobo R.A.; Shimizu H.; Stanczyk F.Z.; Pike M.C.; Henderson B.E.; 5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males. Lancet 1992,339(8798),887-889","journal-title":"Lancet"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1586\/eem.11.20","volume":"6","author":"Nelles J.L.","year":"2011","unstructured":"Nelles J.L.; Hu W-Y.; Prins G.S.; Estrogen action and prostate cancer. Expert Rev Endocrinol Metab 2011,6(3),437-451","journal-title":"Expert Rev Endocrinol Metab"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1097\/00001813-200410000-00004","volume":"15","author":"Kruit W.H.J.","year":"2004","unstructured":"Kruit W.H.J.; Stoter G.; Klijn J.G.M.; Effect of combination therapy with aminoglutethimide and hydrocortisone on prostate-specific antigen response in metastatic prostate cancer refractory to standard endocrine therapy. Anticancer Drugs 2004,15(9),843-847","journal-title":"Anticancer Drugs"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.canlet.2019.09.001","volume":"467","author":"Liang Z.","year":"2019","unstructured":"Liang Z.; Cao J.; Tian L.; Shen Y.; Yang X.; Lin Q.; Zhang R.; Liu H.; Du X.; Shi J.; Zhang J.; Aromatase-induced endogenous estrogen promotes tumour metastasis through estrogen receptor-\u03b1\/matrix metalloproteinase 12 axis activation in castration-resistant prostate cancer. Cancer Lett 2019,467,72-84","journal-title":"Cancer Lett"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/j.fertnstert.2012.10.023","volume":"98","author":"Schlegel P.N.","year":"2012","unstructured":"Schlegel P.N.; Aromatase inhibitors for male infertility. Fertil Steril 2012,98(6),1359-1362","journal-title":"Fertil Steril"},{"key":"ref=57","first-page":"1941","volume":"80","author":"Inkster S.","year":"1995","unstructured":"Inkster S.; Yue W.; Brodie A.; Human testicular aromatase: immunocytochemical and biochemical studies. J Clin Endocrinol Metab 1995,80(6),1941-1947","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/S0022-5347(05)66540-8","volume":"165","author":"Pavlovich C.P.","year":"2001","unstructured":"Pavlovich C.P.; King P.; Goldstein M.; Schlegel P.N.; Evidence of a treatable endocrinopathy in infertile men. J Urol 2001,165(3),837-841","journal-title":"J Urol"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1056\/NEJM199302183280708","volume":"328","author":"Braunstein G.D.","year":"1993","unstructured":"Braunstein G.D.; Gynecomastia. N Engl J Med 1993,328(7),490-495","journal-title":"N Engl J Med"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1677\/erc.0.0060315","volume":"6","author":"Braunstein G.D.","year":"1999","unstructured":"Braunstein G.D.; Aromatase and gynecomastia. Endocr Relat Cancer 1999,6(2),315-324","journal-title":"Endocr Relat Cancer"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/BF02976453","volume":"23","author":"Jeong H-J.","year":"2000","unstructured":"Jeong H-J.; Chang L.C.; Kim H-K.; Kim I-H.; Kinghorn A.D.; Pezzuto J.M.; Aromatase inhibitors from Isodon excisus var. coreanus. Arch Pharm Res 2000,23(3),243-245","journal-title":"Arch Pharm Res"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"3671","DOI":"10.1016\/j.fct.2008.09.045","volume":"46","author":"Yu C.","year":"2008","unstructured":"Yu C.; Li Y.; Chen H.; Yang S.; Xie G.; Decreased expression of aromatase in the Ishikawa and RL95-2 cells by the isoflavone, puerarin, is associated with inhibition of c-jun expression and AP-1 activity. Food Chem Toxicol 2008,46(12),3671-3676","journal-title":"Food Chem Toxicol"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1289\/ehp.9810685","volume":"106","author":"Kao Y.C.","year":"1998","unstructured":"Kao Y.C.; Zhou C.; Sherman M.; Laughton C.A.; Chen S.; Molecular basis of the inhibition of human aromatase (estrogen synthetase) by flavone and isoflavone phytoestrogens: A site-directed mutagenesis study. Environ Health Perspect 1998,106(2),85-92","journal-title":"Environ Health Perspect"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1093\/toxsci\/kfh257","volume":"82","author":"Sanderson J.T.","year":"2004","unstructured":"Sanderson J.T.; Hordijk J.; Denison M.S.; Springsteel M.F.; Nantz M.H.; van den Berg M.; Induction and inhibition of aromatase (CYP19) activity by natural and synthetic flavonoid compounds in H295R human adrenocortical carcinoma cells. Toxicol Sci 2004,82(1),70-79","journal-title":"Toxicol Sci"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.taap.2007.03.016","volume":"221","author":"van Meeuwen J.A.","year":"2007","unstructured":"van Meeuwen J.A.; Korthagen N.; de Jong P.C.; Piersma A.H.; van den Berg M.; (Anti)estrogenic effects of phytochemicals on human primary mammary fibroblasts, MCF-7 cells and their co-culture. Toxicol Appl Pharmacol 2007,221(3),372-383","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.taap.2007.12.007","volume":"228","author":"van Meeuwen J.A.","year":"2008","unstructured":"van Meeuwen J.A.; Nijmeijer S.; Mutarapat T.; Ruchirawat S.; de Jong P.C.; Piersma A.H.; van den Berg M.; Aromatase inhibition by synthetic lactones and flavonoids in human placental microsomes and breast fibroblasts--a comparative study. Toxicol Appl Pharmacol 2008,228(3),269-276","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"543","DOI":"10.2147\/IJWH.S36825","volume":"4","author":"Maia H.","year":"2012","unstructured":"Maia H.; Haddad C.; Pinheiro N.; Casoy J.; Advantages of the association of resveratrol with oral contraceptives for management of endometriosis-related pain. Int J Womens Health 2012,4,543-549","journal-title":"Int J Womens Health"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1126\/science.6474163","volume":"225","author":"Kellis J.T.","year":"1984","unstructured":"Kellis J.T.; Vickery L.E.; Inhibition of human estrogen synthetase (aromatase) by flavones. Science 1984,225(4666),1032-1034","journal-title":"Science"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/0960-0760(90)90335-I","volume":"37","author":"Ibrahim A.R.","year":"1990","unstructured":"Ibrahim A.R.; Abul-Hajj Y.J.; Aromatase inhibition by flavonoids. J Steroid Biochem Mol Biol 1990,37(2),257-260","journal-title":"J Steroid Biochem Mol Biol"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/0960-0760(93)90228-O","volume":"46","author":"Campbell D.R.","year":"1993","unstructured":"Campbell D.R.; Kurzer M.S.; Flavonoid inhibition of aromatase enzyme activity in human preadipocytes. J Steroid Biochem Mol Biol 1993,46(3),381-388","journal-title":"J Steroid Biochem Mol Biol"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1093\/toxsci\/kfj190","volume":"92","author":"Wang Y.","year":"2006","unstructured":"Wang Y.; Lee K.W.; Chan F.L.; Chen S.; Leung L.K.; The red wine polyphenol resveratrol displays bilevel inhibition on aromatase in breast cancer cells. Toxicol Sci 2006,92(1),71-77","journal-title":"Toxicol Sci"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.toxlet.2007.07.009","volume":"173","author":"Wang Y.","year":"2007","unstructured":"Wang Y.; Leung L.K.; Pharmacological concentration of resveratrol suppresses aromatase in JEG-3 cells. Toxicol Lett 2007,173(3),175-180","journal-title":"Toxicol Lett"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.tox.2008.03.017","volume":"248","author":"Wang Y.","year":"2008","unstructured":"Wang Y.; Ye L.; Leung L.K.; A positive feedback pathway of estrogen biosynthesis in breast cancer cells is contained by resveratrol. Toxicology 2008,248(2-3),130-135","journal-title":"Toxicology"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"3846","DOI":"10.2741\/3493","volume":"14","author":"Adams L.S.","year":"2009","unstructured":"Adams L.S.; Chen S.; Phytochemicals for breast cancer prevention by targeting aromatase. Front Biosci 2009,14,3846-3863","journal-title":"Front Biosci"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1002\/jssc.201300474","volume":"36","author":"Zhao H.","year":"2013","unstructured":"Zhao H.; Chen Z.; Screening of aromatase inhibitors in traditional Chinese medicines by electrophoretically mediated microanalysis in a partially filled capillary. J Sep Sci 2013,36(16),2691-2697","journal-title":"J Sep Sci"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.lfs.2004.12.014","volume":"77","author":"Wang Y.","year":"2005","unstructured":"Wang Y.; Chan F.L.; Chen S.; Leung L.K.; The plant polyphenol butein inhibits testosterone-induced proliferation in breast cancer cells expressing aromatase. Life Sci 2005,77(1),39-51","journal-title":"Life Sci"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1002\/ijc.24046","volume":"124","author":"Ye L.","year":"2009","unstructured":"Ye L.; Gho W.M.; Chan F.L.; Chen S.; Leung L.K.; Dietary administration of the licorice flavonoid isoliquiritigenin deters the growth of MCF-7 cells overexpressing aromatase. Int J Cancer 2009,124(5),1028-1036","journal-title":"Int J Cancer"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"48071","DOI":"10.1074\/jbc.M406847200","volume":"279","author":"Chen S.","year":"2004","unstructured":"Chen S.; Cho M.; Karlsberg K.; Zhou D.; Yuan Y-C.; Biochemical and biological characterization of a novel anti-aromatase coumarin derivative. J Biol Chem 2004,279(46),48071-48078","journal-title":"J Biol Chem"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/S0024-3205(00)00435-5","volume":"66","author":"Le Bail J-C.","year":"2000","unstructured":"Le Bail J-C.; Champavier Y.; Chulia A-J.; Habrioux G.; Effects of phytoestrogens on aromatase, 3\u03b2 and 17\u03b2-hydroxysteroid dehydrogenase activities and human breast cancer cells. Life Sci 2000,66(14),1281-1291","journal-title":"Life Sci"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/BF02976369","volume":"22","author":"Jeong H.J.","year":"1999","unstructured":"Jeong H.J.; Shin Y.G.; Kim I.H.; Pezzuto J.M.; Inhibition of aromatase activity by flavonoids. Arch Pharm Res 1999,22(3),309-312","journal-title":"Arch Pharm Res"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/0960-0760(95)00261-8","volume":"57","author":"Pelissero C.","year":"1996","unstructured":"Pelissero C.; Lenczowski M.J.; Chinzi D.; Davail-Cuisset B.; Sumpter J.P.; Fostier A.; Effects of flavonoids on aromatase activity, an in vitro study. J Steroid Biochem Mol Biol 1996,57(3-4),215-223","journal-title":"J Steroid Biochem Mol Biol"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/0960-0760(93)90022-O","volume":"44","author":"Adlercreutz H.","year":"1993","unstructured":"Adlercreutz H.; Bannwart C.; W\u00e4h\u00e4l\u00e4 K.; M\u00e4kel\u00e4 T.; Brunow G.; Hase T.; Arosemena P.J.; Kellis J.T.; Vickery L.E.; Inhibition of human aromatase by mammalian lignans and isoflavonoid phytoestrogens. J Steroid Biochem Mol Biol 1993,44(2),147-153","journal-title":"J Steroid Biochem Mol Biol"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/0960-0760(94)90030-2","volume":"50","author":"Wang C.","year":"1994","unstructured":"Wang C.; M\u00e4kel\u00e4 T.; Hase T.; Adlercreutz H.; Kurzer M.S.; Lignans and flavonoids inhibit aromatase enzyme in human preadipocytes. J Steroid Biochem Mol Biol 1994,50(3-4),205-212","journal-title":"J Steroid Biochem Mol Biol"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/S0278-6915(02)00066-2","volume":"40","author":"Satoh K.","year":"2002","unstructured":"Satoh K.; Sakamoto Y.; Ogata A.; Nagai F.; Mikuriya H.; Numazawa M.; Yamada K.; Aoki N.; Inhibition of aromatase activity by green tea extract catechins and their endocrinological effects of oral administration in rats. Food Chem Toxicol 2002,40(7),925-933","journal-title":"Food Chem Toxicol"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1016\/j.ejca.2004.06.018","volume":"40","author":"Way T-D.","year":"2004","unstructured":"Way T-D.; Lee H-H.; Kao M-C.; Lin J-K.; Black tea polyphenol theaflavins inhibit aromatase activity and attenuate tamoxifen resistance in HER2\/neu-transfected human breast cancer cells through tyrosine kinase suppression. Eur J Cancer 2004,40(14),2165-2174","journal-title":"Eur J Cancer"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1080\/00498254.2018.1482029","volume":"49","author":"Ozcan-Sezer S.","year":"2019","unstructured":"Ozcan-Sezer S.; Ince E.; Akdemir A.; Ceylan \u00d6.\u00d6.; Suzen S.; Gurer-Orhan H.; Aromatase inhibition by 2-methyl indole hydrazone derivatives evaluated via molecular docking and in vitro activity studies. Xenobiotica 2019,49(5),549-556","journal-title":"Xenobiotica"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1172\/JCI112494","volume":"77","author":"Barbieri R.L.","year":"1986","unstructured":"Barbieri R.L.; Gochberg J.; Ryan K.J.; Nicotine, cotinine, and anabasine inhibit aromatase in human trophoblast in vitro. J Clin Invest 1986,77(6),1727-1733","journal-title":"J Clin Invest"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/0304-3835(93)90060-M","volume":"75","author":"Kadohama N.","year":"1993","unstructured":"Kadohama N.; Shintani K.; Osawa Y.; Tobacco alkaloid derivatives as inhibitors of breast cancer aromatase. Cancer Lett 1993,75(3),175-182","journal-title":"Cancer Lett"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"173154","DOI":"10.1016\/j.ejphar.2020.173154","volume":"879","author":"Du B.W.","year":"2020","unstructured":"Du B.W.; Zhang X.J.; Shi N.; Peng T.; Gao J.B.; Azimova B.; Zhang R.; Pu D.B.; Wang C.; Abduvaliev A.; Rakhmanov A.; Zhang G.L.; Xiao W.L.; Wang F.; Luteolin-7-methylether from Leonurus japonicus inhibits estrogen biosynthesis in human ovarian granulosa cells by suppression of aromatase (CYP19). Eur J Pharmacol 2020,879,173154","journal-title":"Eur J Pharmacol"}],"container-title":["Current Topics in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1568026621666211129141631","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/198409\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1568026621666211129141631","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,12]],"date-time":"2023-08-12T18:49:43Z","timestamp":1691866183000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/198409\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":89,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1568026621666211129141631","relation":{},"ISSN":["1568-0266"],"issn-type":[{"value":"1568-0266","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-05-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-10-17","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-10-31","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-04","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}